Septerna to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — Septerna, a clinical-stage biotechnology company pioneering a new era of […]
ALX Oncology to Present Updated Results from Phase 2 ASPEN-06 Clinical Trial of Evorpacept in Patients with HER2-Positive Gastric Cancer in Oral Presentation at 2025 ASCO Gastrointestinal Cancers Symposium
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology” or “the Company”) (Nasdaq: […]
ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco
ZyVersa is advancing a pipeline of first-in-class drug candidates built around two proprietary technologies. – Inflammasome ASC Inhibitor IC 100 […]
Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
Key preclinical milestone for novel, non-opioid extended-release pain therapeutic SARASOTA, FL, Dec. 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. […]
Ressources Cerro de Pasco annonce des résultats additionnels pour la zone d’argent-zinc-plomb de Quiulacocha
MONTRÉAL, 18 déc. 2024 (GLOBE NEWSWIRE) — Ressources Cerro de Pasco Inc. (CSE : CDPR) (OTCQB : GPPRF) (FRA : […]
Cerro de Pasco Resources Reports Additional Results from the Quiulacocha Silver-Zinc-Lead Zone
MONTREAL, Dec. 18, 2024 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCQB: GPPRF) (FRA: N8HP) (“CDPR” or […]
Mesoblast to be Added to Nasdaq Biotechnology Index
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory […]
Amesite Announces NurseMagic™ Enterprise Contract Wins in High Growth Companies with Hundreds of Franchise Owners
DETROIT, Dec. 18, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), creator of the NurseMagic™ app, has closed on contracts […]
